Related Experiment Video
Updated: Aug 18, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Growth factor NUN increased AKR1C2 expression by activated CDK2 related RB signal transduction pathway in human liver
1Tsinghua Institute of Genome Research, Institute of Biomedicine, School of Medicine, Tsinghua University, Beijing, People's Republic of China. Ludondon88@163.com
Background/Aims:
The investigation is to understand whether polypeptide growth factor NUN can enhance AKR1C2 transcriptional expression in human SMMC7721 liver cancer cell line or not.
Methodology:
SMMC7721 cell was starved in serum-free medium overnight before NUN treatment, and cells were then incubated with NUN for different times and dosage. These cells lysates were prepared to examine AKR1C2 expression by Western blot. Total RNA was extracted from these cells to analyze the change of AKR1C2 mRNA by Northern blot.
Results:
NUN increased expression of AKR1C2 in SMMC7721 liver cancer cell in a time- and dosage-dependent manner and this increase resulted from up-regulation of AKR1C2 mRNA expression. The inhibitor of CDK2 inhibited the up-regulation of AKR1C2 by NUN.
Conclusions:
These results showed that NUN can enhance AKR1C2 transcription by activated CDK2 related RB signaling pathway, leading to increased AKR1C2 expression in SMMC7721 liver cancer cell.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Mitogens and the Cell Cycle
The Ras Gene
Ras is a superfamily...
MAPK Signaling Cascades
Inhibition of Cdk Activity